These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Is β-Lactam Plus Macrolide More Effective than β-Lactam Plus Fluoroquinolone among Patients with Severe Community-Acquired Pneumonia?: a Systemic Review and Meta-Analysis. Lee JH, Kim HJ, Kim YH. J Korean Med Sci; 2017 Jan 02; 32(1):77-84. PubMed ID: 27914135 [Abstract] [Full Text] [Related]
18. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia. Mortensen EM, Restrepo MI, Anzueto A, Pugh J. Crit Care; 2005 Dec 06; 10(1):R8. PubMed ID: 16420641 [Abstract] [Full Text] [Related]
19. Comparative Efficacy of Beta-Lactams and Macrolides in the Treatment of Pediatric Pneumonia: A Systematic Review. Al Saeedy D, Gillani SW, Al-Salloum J, Moosvi A, Eissa M, Gulam SM. Curr Pediatr Rev; 2020 Dec 06; 16(4):307-313. PubMed ID: 32895041 [Abstract] [Full Text] [Related]
20. The order of administration of macrolides and beta-lactams may impact the outcomes of hospitalized patients with community-acquired pneumonia: results from the community-acquired pneumonia organization. Peyrani P, Wiemken TL, Metersky ML, Arnold FW, Mattingly WA, Feldman C, Cavallazzi R, Fernandez-Botran R, Bordon J, Ramirez JA. Infect Dis (Lond); 2018 Jan 06; 50(1):13-20. PubMed ID: 28699429 [Abstract] [Full Text] [Related] Page: [Next] [New Search]